UK healthcare professionals’ uncertainties, barriers and facilitators to the introduction of targeted HPV vaccination for men who have sex with men: a qualitative analysis
UK healthcare professionals’ uncertainties, barriers and facilitators to the introduction of targeted HPV vaccination for men who have sex with men: a qualitative analysis
Background: female-only HPV vaccination will fail to protect MSM against HPV and its sequelae i.e. genital warts and anal cancers. In the absence of gender-neutral HPV vaccination, targeted vaccination for MSM at sexual health clinics offers a valuable preventive opportunity. We aimed to identify sexual healthcare professionals’ (HCPs) perceived barriers and facilitators for MSM-targeted HPV vaccination.
Methods: nineteen telephone interviews, with UK-based self-referred HCPs (13 doctors, 3 nurses, 3 health advisers), were conducted in October and November 2014. The interviews were recorded and transcribed verbatim. Data were analysed thematically by two researchers.
Results: HCPs were unsure about selection criteria, acceptable healthcare settings and the source of vaccination funding for the introduction of MSM-targeted HPV vaccination. The lack of political and public support, MSMs’ restricted access to HPV vaccination and disclosure of sexual orientation to HCPs, identification of eligible MSM, poor HPV awareness and motivation to complete HPV vaccination were perceived as significant barriers. HCPs believed that the introduction of official guidelines on HPV vaccination for MSM, awareness campaigns and integrated clinic procedures could improve vaccination coverage.
Conclusion: HCPs recognised a need to protect MSM against HPV. However, several challenges and obstacles associated with the introduction of MSM-targeted HPV vaccination in the UK were reported. HCPs’ perspectives and concerns need to be addressed when developing policies and guidelines for a potential MSM-targeted HPV vaccination. Future research needs to examine whether negative views of HCPs towards MSM-targeted HPV vaccination are associated with lower HPV vaccine uptake and completion rates in MSM.
372-377
Nadarzynski, Tomasz
218d69a1-d1be-46f4-bead-23071bd4f270
Llewellyn, Carrie
f618e0d0-7b27-4132-b92c-e977422d9439
Richardson, Daniel
3eac3883-af2a-411b-bf18-f0668f9f8a2b
Pollard, Alex
2e7c65e8-af16-4fd6-ab54-8b51f2c1a0d3
Smith, Helen
6020686f-a513-41c0-b7b7-c3e9fc0e133b
Nadarzynski, Tomasz
218d69a1-d1be-46f4-bead-23071bd4f270
Llewellyn, Carrie
f618e0d0-7b27-4132-b92c-e977422d9439
Richardson, Daniel
3eac3883-af2a-411b-bf18-f0668f9f8a2b
Pollard, Alex
2e7c65e8-af16-4fd6-ab54-8b51f2c1a0d3
Smith, Helen
6020686f-a513-41c0-b7b7-c3e9fc0e133b
Nadarzynski, Tomasz, Llewellyn, Carrie, Richardson, Daniel, Pollard, Alex and Smith, Helen
(2017)
UK healthcare professionals’ uncertainties, barriers and facilitators to the introduction of targeted HPV vaccination for men who have sex with men: a qualitative analysis.
Sexual Health, 14 (4), .
(doi:10.1071/SH17026).
Abstract
Background: female-only HPV vaccination will fail to protect MSM against HPV and its sequelae i.e. genital warts and anal cancers. In the absence of gender-neutral HPV vaccination, targeted vaccination for MSM at sexual health clinics offers a valuable preventive opportunity. We aimed to identify sexual healthcare professionals’ (HCPs) perceived barriers and facilitators for MSM-targeted HPV vaccination.
Methods: nineteen telephone interviews, with UK-based self-referred HCPs (13 doctors, 3 nurses, 3 health advisers), were conducted in October and November 2014. The interviews were recorded and transcribed verbatim. Data were analysed thematically by two researchers.
Results: HCPs were unsure about selection criteria, acceptable healthcare settings and the source of vaccination funding for the introduction of MSM-targeted HPV vaccination. The lack of political and public support, MSMs’ restricted access to HPV vaccination and disclosure of sexual orientation to HCPs, identification of eligible MSM, poor HPV awareness and motivation to complete HPV vaccination were perceived as significant barriers. HCPs believed that the introduction of official guidelines on HPV vaccination for MSM, awareness campaigns and integrated clinic procedures could improve vaccination coverage.
Conclusion: HCPs recognised a need to protect MSM against HPV. However, several challenges and obstacles associated with the introduction of MSM-targeted HPV vaccination in the UK were reported. HCPs’ perspectives and concerns need to be addressed when developing policies and guidelines for a potential MSM-targeted HPV vaccination. Future research needs to examine whether negative views of HCPs towards MSM-targeted HPV vaccination are associated with lower HPV vaccine uptake and completion rates in MSM.
Text
Nadarzynski HCP accepted
- Accepted Manuscript
More information
Accepted/In Press date: 3 April 2017
e-pub ahead of print date: 8 June 2017
Identifiers
Local EPrints ID: 412446
URI: http://eprints.soton.ac.uk/id/eprint/412446
ISSN: 1448-5028
PURE UUID: 9f75dcf7-6c1c-4ab1-881b-1638f54ebb61
Catalogue record
Date deposited: 17 Jul 2017 13:46
Last modified: 15 Mar 2024 13:29
Export record
Altmetrics
Contributors
Author:
Tomasz Nadarzynski
Author:
Carrie Llewellyn
Author:
Daniel Richardson
Author:
Alex Pollard
Author:
Helen Smith
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics